Clinical trial
Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia in a Real Life Setting in Canada
NCT05611528 is registered in ClinicalTrials.gov with Daniel Gaudet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia in a Real Life Setting in Canada
- Lead sponsor
- Daniel Gaudet
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 21, 2023
- Completion date
- March 18, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.